NASDAQ:INBS Intelligent Bio Solutions (INBS) Stock Price, News & Analysis → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free INBS Stock Alerts $2.47 -0.03 (-1.20%) (As of 04:27 PM ET) Add Compare Share Share Today's Range$2.38▼$2.5550-Day Range$2.47▼$5.5752-Week Range$2.28▼$44.88Volume51,403 shsAverage Volume2.29 million shsMarket Capitalization$7.02 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get Intelligent Bio Solutions alerts: Email Address Intelligent Bio Solutions MarketRank™ Stock AnalysisAnalyst RatingN/AUpside/DownsideN/AShort InterestHealthy2.61% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.71Based on 4 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($3.67) to ($1.25) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.43 out of 5 stars N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for Intelligent Bio Solutions.Read more about Intelligent Bio Solutions' stock forecast and price target. Previous Next 3.0 Short Interest Percentage of Shares Shorted2.61% of the float of Intelligent Bio Solutions has been sold short.Short Interest Ratio / Days to CoverIntelligent Bio Solutions has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Intelligent Bio Solutions has recently increased by 2.65%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldIntelligent Bio Solutions does not currently pay a dividend.Dividend GrowthIntelligent Bio Solutions does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for INBS. Previous Next 2.6 News and Social Media Coverage News SentimentIntelligent Bio Solutions has a news sentiment score of 0.71. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.36 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Intelligent Bio Solutions this week, compared to 1 article on an average week.Search InterestOnly 1 people have searched for INBS on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Intelligent Bio Solutions to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Intelligent Bio Solutions insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.28% of the stock of Intelligent Bio Solutions is held by insiders.Percentage Held by InstitutionsOnly 32.97% of the stock of Intelligent Bio Solutions is held by institutions.Read more about Intelligent Bio Solutions' insider trading history. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Intelligent Bio Solutions are expected to grow in the coming year, from ($3.67) to ($1.25) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Intelligent Bio Solutions is -0.02, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Intelligent Bio Solutions is -0.02, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioIntelligent Bio Solutions has a P/B Ratio of 0.13. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Intelligent Bio Solutions' valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Crypto Swap ProfitsDid You Get Your Free Bitcoin Yet?And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here About Intelligent Bio Solutions Stock (NASDAQ:INBS)Intelligent Bio Solutions Inc., a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.Read More INBS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart INBS Stock News HeadlinesMay 8, 2024 | investorplace.comINBS Stock Earnings: Intelligent Bio Solutions Beats EPS, Misses Revenue for Q3 2024May 8, 2024 | markets.businessinsider.comIntelligent Bio Solutions Inc. Reports Fiscal 2024 Third Quarter and Nine-Month Financial Results and Operational HighlightsMay 9, 2024 | Gold Safe Exchange (Ad)Trump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.May 8, 2024 | globenewswire.comIntelligent Bio Solutions Inc. Reports Fiscal 2024 Third Quarter and Nine-Month Financial Results and Operational HighlightsApril 18, 2024 | finanznachrichten.deIntelligent Bio Solutions, Inc.: Intelligent Bio Solutions Inc. Announces Preliminary Unaudited Fiscal Third Quarter and Nine-Month Revenue ResultsApril 18, 2024 | globenewswire.comIntelligent Bio Solutions Inc. Announces Preliminary Unaudited Fiscal Third Quarter and Nine-Month Revenue ResultsApril 11, 2024 | globenewswire.comIntelligent Bio Solutions Subsidiary Broadens Intellectual Property Portfolio with Grant of New European Patent with Unitary Effect for Innovative Intelligent Fingerprinting DSR-Plus Cartridge ReaderMarch 26, 2024 | globenewswire.comIntelligent Bio Solutions to Present at the LD Micro Invitational XIV Investor Conference on April 9 in NYCMay 9, 2024 | Gold Safe Exchange (Ad)Trump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.March 12, 2024 | globenewswire.comIntelligent Bio Solutions Announces Closing of $10.1 Million Private Placement Priced At-the-Market Under Nasdaq RulesMarch 11, 2024 | msn.comIntelligent BIO Ekes up on Private PlacementMarch 11, 2024 | markets.businessinsider.comIntelligent Bio Solutions Announces $10.1 Mln Private PlacementMarch 11, 2024 | finance.yahoo.comIntelligent Bio Solutions Announces $10.1 Million Private Placement Priced At-the-Market Under Nasdaq RulesMarch 11, 2024 | globenewswire.comIntelligent Bio Solutions Announces $10.1 Million Private Placement Priced At-the-Market Under Nasdaq RulesMarch 1, 2024 | globenewswire.comIntelligent Bio Solutions Inc. to Present at the Emerging Growth Conference on March 6, 2024February 29, 2024 | msn.comIntelligent Bio Solutions seeks 510(k) approval with drug screening studyFebruary 28, 2024 | finanznachrichten.deIntelligent Bio Solutions, Inc.: Intelligent Bio Solutions Partners with Cliantha Research to Conduct Clinical Study as Part of FDA 510(k) PathwayFebruary 28, 2024 | globenewswire.comIntelligent Bio Solutions Partners with Cliantha Research to Conduct Clinical Study as Part of FDA 510(k) PathwayFebruary 20, 2024 | benzinga.comPeering Into Intelligent Bio Solutions's Recent Short InterestFebruary 16, 2024 | finance.yahoo.comIntelligent Bio Solutions Inc. Regains Compliance with Nasdaq Minimum Bid Price Requirement and Confirms Compliance with Minimum Stockholders’ Equity RequirementFebruary 16, 2024 | globenewswire.comIntelligent Bio Solutions Inc. Regains Compliance with Nasdaq Minimum Bid Price Requirement and Confirms Compliance with Minimum Stockholders' Equity RequirementFebruary 11, 2024 | finance.yahoo.comIntelligent Bio Solutions Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues LagFebruary 9, 2024 | finance.yahoo.comIntelligent Bio Solutions Inc. Reports Fiscal Second Quarter and Six-Month Financial Results and Operational HighlightsFebruary 5, 2024 | msn.comWhy Is Intelligent Bio Solutions Stock Tumbling Today?February 5, 2024 | finance.yahoo.comIntelligent Bio Solutions Inc. Announces Exercise of Previously Issued Warrants for $1.77 Million in Gross ProceedsFebruary 2, 2024 | msn.comWhy Intelligent Bio Solutions Shares Are Skyrocketing TodayFebruary 2, 2024 | markets.businessinsider.comIntelligent Bio Solutions Expects Higher Q2 Revenue, Stock Up In Pre-MarketSee More Headlines Receive INBS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Intelligent Bio Solutions and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/09/2024Today5/09/2024Next Earnings (Estimated)5/09/2024Fiscal Year End6/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:INBS CUSIPN/A CIK1725430 Webgbs.inc Phone646-828-8258FaxN/AEmployees51Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($106.15) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-10,630,000.00 Net Margins-544.63% Pretax Margin-546.02% Return on Equity-266.16% Return on Assets-96.52% Debt Debt-to-Equity Ratio0.07 Current Ratio0.57 Quick Ratio0.39 Sales & Book Value Annual Sales$2.46 million Price / Sales2.89 Cash FlowN/A Price / Cash FlowN/A Book Value$18.99 per share Price / Book0.13Miscellaneous Outstanding Shares2,844,000Free Float2,836,000Market Cap$7.11 million OptionableNot Optionable Beta4.87 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesMr. Harry Simeonidis (Age 57)President & CEO Comp: $310.79kMr. Spiro Kevin Sakiris B.Bus (Age 62)C.A., CA, Dip Law, Chief Financial Officer Comp: $274.43kMs. Victoria Gavrilenko (Age 41)Operations Manager Comp: $45kMr. Alex ArzenoVP of Investor RelationsKey CompetitorsVivos TherapeuticsNASDAQ:VVOSVapothermNYSE:VAPOAvingerNASDAQ:AVGRProSomnusNASDAQ:OSANeuroMetrixNASDAQ:NUROView All CompetitorsInsiders & InstitutionsCVI Holdings LLCBought 108,250 shares on 5/7/2024Ownership: 3.812%Harry SimeonidisBought 8 shares on 8/31/2023Total: $184.32 ($23.04/share)View All Insider TransactionsView All Institutional Transactions INBS Stock Analysis - Frequently Asked Questions How have INBS shares performed in 2024? Intelligent Bio Solutions' stock was trading at $4.0548 at the beginning of 2024. Since then, INBS stock has decreased by 40.1% and is now trading at $2.43. View the best growth stocks for 2024 here. Are investors shorting Intelligent Bio Solutions? Intelligent Bio Solutions saw a drop in short interest in the month of March. As of March 31st, there was short interest totaling 71,600 shares, a drop of 21.3% from the March 15th total of 91,000 shares. Based on an average daily trading volume, of 3,150,000 shares, the days-to-cover ratio is currently 0.0 days. Approximately 2.5% of the shares of the stock are short sold. View Intelligent Bio Solutions' Short Interest. When is Intelligent Bio Solutions' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, August 22nd 2024. View our INBS earnings forecast. How were Intelligent Bio Solutions' earnings last quarter? Intelligent Bio Solutions Inc. (NASDAQ:INBS) announced its quarterly earnings results on Friday, February, 9th. The company reported ($2.07) EPS for the quarter, topping the consensus estimate of ($3.24) by $1.17. The business earned $0.76 million during the quarter. Intelligent Bio Solutions had a negative trailing twelve-month return on equity of 266.16% and a negative net margin of 544.63%. When did Intelligent Bio Solutions' stock split? Intelligent Bio Solutions shares reverse split before market open on Monday, January 29th 2024. The 1-12 reverse split was announced on Monday, January 29th 2024. The number of shares owned by shareholders was adjusted after the market closes on Monday, January 29th 2024. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split. What guidance has Intelligent Bio Solutions issued on next quarter's earnings? Intelligent Bio Solutions issued an update on its third quarter 2024 earnings guidance on Thursday, April, 18th. The company provided EPS guidance of for the period. The company issued revenue guidance of 820000.000-820000.000, compared to the consensus revenue estimate of $1.2 million. Who are Intelligent Bio Solutions' major shareholders? Intelligent Bio Solutions' stock is owned by a number of retail and institutional investors. Top institutional shareholders include CVI Holdings LLC (3.81%). View institutional ownership trends. How do I buy shares of Intelligent Bio Solutions? Shares of INBS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:INBS) was last updated on 5/9/2024 by MarketBeat.com Staff From Our Partners1970’s computer coder Issues Shocking AI WarningInvestorPlaceDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe Crypto 9-5 Escape PlanCrypto 101 MediaThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market Insiders348 million Americans lives to END as we know it?The Oxford ClubObama’s Forever Term [exposed]Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Intelligent Bio Solutions Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
